| Targeting ferritinophagy to iron out Tet2-mutant cells | Blood |  | | 2025 | 3 | 8 |
|
| Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemia | Communications biology | | | 2025 | 3 | 5 |
|
| The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell-cycle progression in acute myeloid leukemia | Blood advances | | | 2025 | 79 | 202 |
|
| Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models | Science translational medicine |  | | 2024 | 190 | 0 |
|
| Selective haematological cancer eradication with preserved haematopoiesis | Nature | | | 2024 | 156 | 108 |
|
| Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia | Blood advances | | | 2023 | 180 | 364 |
|
| Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia | Leukemia | | | 2023 | 82 | 148 |
|
| An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML | Cancer discovery | | | 2022 | 369 | 377 |
|
| AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia | Cancers | | | 2021 | 212 | 98 |
|
